CR test can be used to monitor the anticoagulant effect of LMWH.
CR值有可能成为LMWH抗凝活性的床旁检测指标。
Objective To explore thrombolysis action of low molecular weight heparin (LMWH).
目的探讨低分子肝素(L MWH)的溶栓作用。
LMWH is efficacious, safe and simple for the treatment of acute cerebral infarction.
低分子肝素治疗急性脑梗死是有效、安全、简便的。
International Circulation: Which LMWH would you normally choose to use in ACS patients?
《国际循环》：对ACS患者通常你会选择使用哪种低分子量肝素？
Result: LMWH was better than common heparin in treating ACS patients, the complications of LMWH is less.
结果：低分子肝素疗效优于普通肝素，且并发症少。
Methods: Patients were randomly divided into LMWH plus aspirin treatment group and aspirin control group.
方法：病人被随机分成低分子肝素加阿斯匹林治疗组和阿斯匹林对照组。
Purpose To study purification method of the low molecular weight heparin(LMWH) by affinity chromatography.
目的探索亲和色谱纯化低分子肝素的方法。
Conclution: Early administration of LMWH in UA can improve the prognosis and reduce the incidence of adverse.
结论：早期应用LMWH治疗UA可以改善预后，降低副反应的发生率。
The control group received LMWH, insulin therapy, on this basis, combined with the observation group PE treatment.
对照组采取LMWH、胰岛素治疗，在此基础上，观察组联合PE治疗。
AIM: To study the effect and safety of low-molecular-weight heparin (LMWH) in the treatment of acute ischemic stroke.
目的：评价低分子肝素(LMWH)治疗急性缺血性中风的疗效和安全性。
OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin (LMWH).
目的测定低分子肝素的分子量及其分布。
The study provided the theoretical foundation and experiment evidence for preparing oral drug delivery system of LMWH.
本课题为进一步研制LMWH口服给药系统奠定了理论基础和实验依据。
Objective To explore the application of low-molecular-weight heparin (LMWH) in the procedure of coronary stent implantation.
目的探讨低分子肝素(LMWH)在冠状动脉支架术中的应用价值及安全性。
Conclusion The use of LMWH combined with urokinase in treating recurrent TIA was an efficacious treatment with good security.
结论应用低分子肝素联合尿激酶治疗频发TIA是一种有效、安全的治疗方法。
Conclusions Different dosages of LMWH could effectively improve neurological impairment and the prognosis of patients with ACI.
结论不同剂量lmwh均可改善ACI患者的神经功能和预后。
AIM To test gelatin microspheres of low molecular weight heparin (LMWH-GMS) release behavior; lung target behavior and stability.
目的考察低分子肝素肺靶向微球缓释性、稳定性和靶向性。
In the treating group, LMWH combined with urokinase were given, while in the control group merely hypervolemic treatment was given.
治疗组应用低分子肝素联合尿激酶，对照组仅用扩容治疗。
Other on-going studies are evaluating LMWH indications in pulmonary embolism, artery disease, pregnancy or other medical conditions.
其他正在进行的研究正在评估中的低分子肝素迹象肺栓塞，冠状动脉疾病，怀孕或其他医疗条件。
This study is to observe the clinical validity of the LMWH Sodium preventing and controlling the Henoch-Schoenlein Purpura Nephritis.
本研究旨在观察低分子肝素钠防治过敏性紫癜肾损害的临床有效性。
Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulability in acute Kawasaki disease(KD).
目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。
Objective To observe the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of primary nephrotic syndrome.
目的观察低分子量肝素对原发性肾病综合征的治疗作用。
For these patients, we recommend subsequent anticoagulant therapy with VKA or LMWH indefinitely or until the cancer is resolved (Grade 1c).
对于上述患者，我们推荐接下来使用VKA或LMWH无限期抗凝治疗或者直到癌症缓解(1 C)。
Objective to determine the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of unstable angina pectoris (UAP).
目的探讨低分子质量肝素(LMWH)治疗不稳定型心绞痛(uap)效果。
The LMWH Sodium can directly affect the occurrence mechanism of the immune complex nephritis, and prevents the immune complex depositing at GBM.
低分子肝素钠还能直接影响免疫复合物肾炎的发生机制，阻止免疫复合物在GBM沉积。
The studies were generally adequately performed but inclusion of a comparator like a UFH or a LMWH would have been useful in the outcome assessment.
试验总体上完成得比较全面，但纳入一个对照药物如UFH或LMWH在结局评价中会更加有利。
Objective To observe the curative effect of different dosages of low molecular weight heparin (LMWH) in patients with acute cerebral infarction (ACI).
目的观察不同剂量低分子肝素(LMWH)对急性脑梗死(aci)患者的疗效。
Objective To evaluate the effects of low molecular weight heparin (LMWH) on serum interleukin-8 (IL-8) in patients with primary nephrotic syndrome (PNS).
目的观察低分子肝素钠对原发性肾病综合征(PNS)患者血浆白介素- 8 (IL - 8)的影响。
Objective To investigate the relationship between local compression and local hemorrhage after low molecular weight heparin (LMWH) subcutaneous injection.
目的探讨低分子肝素(LMWH)皮下注射后局部压迫与否与局部出血的关系。
Objective The aim of this study were to evaluate the value of activated partial thromboplastin time(APTT) in monitoring low-molecular weight heparin(LMWH).
目的进一步探讨活化的部分凝血活酶时间（APTT）对低分子量肝素（LMWH）治疗的实验监测价值。
Objective To evaluate the efficacy and safety of low-molecular-weight heparin(LMWH) in preventing for deep-vein thrombosis (DVT) after total hip replace(THR).
目的探讨人工髋关节置换术（THR）后用低分子肝素预防下肢深静脉血栓（DVT）形成的疗效和安全性。
应用推荐